UBS Reiterates a 'Neutral' on Weingarten (WRI); Raising PT & Estimates
Tweet
Share
E-mailGet Alerts WRI Hot Sheet
Price: $31.44 --0%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
UBS reiterates a 'Neutral' on Weingarten (NYSE: WRI) price target raised from $21 to $24.
UBS analyst said, "We favor Weingarten’s long term strategy of recycling capital into higher quality acquisitions and development while selling non-core assets, despite the near term dilutive impact, as we believe it ultimately results in long term NAV creation. We also see the 4.6% dividend yield as providing support for the stock (vs. the REIT average of 3.6%). That said, the full valuation keeps us at Neutral."
UBS raised FY12 EPS estimate from $1.83 to $1.88 and FY13 from $1.88 to $1.91.
For an analyst ratings summary and ratings history on Weingarten click here. For more ratings news on Weingarten click here.
Shares of Weingarten closed at $25.21 yesterday.
UBS analyst said, "We favor Weingarten’s long term strategy of recycling capital into higher quality acquisitions and development while selling non-core assets, despite the near term dilutive impact, as we believe it ultimately results in long term NAV creation. We also see the 4.6% dividend yield as providing support for the stock (vs. the REIT average of 3.6%). That said, the full valuation keeps us at Neutral."
UBS raised FY12 EPS estimate from $1.83 to $1.88 and FY13 from $1.88 to $1.91.
For an analyst ratings summary and ratings history on Weingarten click here. For more ratings news on Weingarten click here.
Shares of Weingarten closed at $25.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
- Jefferies Downgrades Enphase Energy (ENPH) to Hold, 'Still Muddling Through'
- GE Aerospace (GE) PT Raised to $180 at BofA Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
